Smith & Nephew plc (SNNUF)
| Previous Close | 15.50 |
| Open | 15.50 |
| Bid | 15.10 x 45900 |
| Ask | 16.40 x 36900 |
| Day's Range | 15.50 - 15.50 |
| 52 Week Range | 10.80 - 15.70 |
| Volume | |
| Avg. Volume | 1,069 |
| Market Cap | 13.709B |
| Beta (5Y Monthly) | 0.62 |
| PE Ratio (TTM) | 44.60 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.38 (2.40%) |
| Ex-Dividend Date | Oct 03, 2024 |
| 1y Target Est | N/A |
- Zacks
SNN Stock Declines Despite the Launch of Its Patient-Matched Guides
Smith & Nephew announces the launch of its TOTAL ANKLE Patient-Matched Guides to plan and perform total ankle replacement procedures.
- Simply Wall St.
3 UK Stocks Estimated To Be Trading At Up To 41.4% Discount
The UK stock market has recently faced challenges, with the FTSE 100 closing lower due to weak trade data from China and falling commodity prices impacting key sectors. Despite these headwinds, there are opportunities for discerning investors to find undervalued stocks that may be trading at significant discounts. Identifying such stocks requires careful analysis of their fundamentals and potential for recovery in the current economic landscape.
- Simply Wall St.
3 UK Stocks That Could Be Trading Up To 40.7% Below Intrinsic Value Estimates
The recent performance of the FTSE 100, influenced by weak trade data from China and falling commodity prices, has highlighted vulnerabilities in the UK market. In such a climate, identifying undervalued stocks that could be trading significantly below their intrinsic value becomes crucial for investors looking to capitalize on potential growth opportunities.
